510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K011389Substantially Equivalent

Hemoglobin F & A2 Control (Beta-Thalassaemia Control)

Canterbury Health Laboratories, Christchurch, Canterbury, NZ / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K011389 is the FDA 510(k) clearance record for HEMOGLOBIN F & A2 CONTROL (BETA-THALASSAEMIA CONTROL), a class II device, cleared for Canterbury Health Laboratories on under FDA product code JCM (Control, Hemoglobin, Abnormal). FDA records list one 510(k) clearance for Canterbury Health Laboratories. As of , FDA records show no recalls naming K011389.

Clearance record

Decision date
Received
(45 days to decision)
Product code
JCM Control, Hemoglobin, Abnormal
Regulation
21 CFR 864.7415
Device class
Class II
Review panel
Hematology
Applicant
Canterbury Health Laboratories Hagley Ave., Christchurch, Canterbury, NZ
510(k) summary
Summary
Third party review
No

Clearances, product code JCM

Trailing 12 months

FDA records hold no clearances under product code JCM in the trailing twelve months.

FDA records show no clearances under product code JCM in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JCM, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260